Literature DB >> 8330105

The composition of the negative syndrome of chronic schizophrenia.

D A Kibel1, I Laffont, P F Liddle.   

Abstract

The clinical features of patients who satisfy a variety of criteria for the negative syndrome can be arranged in five groups of phenomena: (a) poverty of thought and speech, (b) blunted affect, (c) decreased motor activity, (d) apathy and abolition, and (e) diminished interpersonal interaction. We have shown that depressed mood and depressive cognition are not related to the negative syndrome, but there is some overlap between the specific phenomena of depressive illness and negative symptoms in schizophrenia. Items measuring cognitive impairment have a moderate correlation with the negative syndrome, but the negative syndrome accounts for less than half of the variance of cognitive performance. These items that define the negative syndrome can be as reliably measured as depressive and positive symptoms.

Entities:  

Mesh:

Year:  1993        PMID: 8330105     DOI: 10.1192/bjp.162.6.744

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  7 in total

1.  The burden of depressive symptoms in the long-term treatment of patients with schizophrenia.

Authors:  Robert R Conley; Haya Ascher-Svanum; Baojin Zhu; Douglas E Faries; Bruce J Kinon
Journal:  Schizophr Res       Date:  2006-11-15       Impact factor: 4.939

Review 2.  First- and second-generation antipsychotic medication and cognitive processing in schizophrenia.

Authors:  Thomas W Weickert; Terry E Goldberg
Journal:  Curr Psychiatry Rep       Date:  2005-08       Impact factor: 5.285

3.  Comorbidity in Schizophrenia: Conceptual Issues and Clinical Management.

Authors:  Hussain Muhammad Abdullah; Hameed Azeb Shahul; Michael Y Hwang; Stephen Ferrando
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-11-05

Review 4.  Postpsychotic depression in schizophrenia patients.

Authors:  Christian G Kohler; Elise A Lallart
Journal:  Curr Psychiatry Rep       Date:  2002-08       Impact factor: 5.285

5.  Reemergence of positive symptoms of schizophrenia during the course of treatment with risperidone.

Authors:  P Bajaj; N Nihalani; N Shah; N Desai; V Shinde; N Raut
Journal:  Indian J Psychiatry       Date:  1999-04       Impact factor: 1.759

6.  Inner connections within domain of dementia praecox: role of supervisory mental processes in schizophrenia.

Authors:  P F Liddle
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

7.  White Matter Integrity in Genetic High-Risk Individuals and First-Episode Schizophrenia Patients: Similarities and Disassociations.

Authors:  Yifang Zhou; Jie Liu; Naomi Driesen; Fay Womer; Kaiyuan Chen; Ye Wang; Xiaowei Jiang; Qian Zhou; Chuan Bai; Dahai Wang; Yanqing Tang; Fei Wang
Journal:  Biomed Res Int       Date:  2017-03-19       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.